Issue: April 2014
April 01, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
SPS3
Issue: April 2014
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Researchers investigated whether combination antiplatelet therapy (aspirin and clopidogrel) was more effective than aspirin alone for the prevention of cognitive decline, and if intensive BP control was associated with less cognitive decline.